Reducing Racial Disparities in Cancer Care With PINPOINT (Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 81
- 试验地点
- 2
- 主要终点
- Community Advisory Board, Key Informants and Pilot Testers
研究概览
简要总结
The purpose of the research is to: develop an educational website to empower Black and African American cancer patients to make informed decisions about personalized cancer treatment and clinical trials. The sample size for the qualitative interviews was (n=48) when saturation was achieved. With a goal of (n=33) for the pilot trial, the overall target sample size for the study is (n=81).
详细描述
The website offers tools for discussing innovative treatments with their clinicians, finding clinical trials, and locating support groups. We are conducting key informant interviews, testing the website with pilot tester and asking volunteers from our Community Advisory Board to review our website prototype to further improve its design and features.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Patient Key Informant:
- •Age 18 and older
- •Self-identify as Black/African American
- •Diagnosed with solid tumor
- •Able to read and speak English fluently
- •Able to provide informed consent
- •Able to complete 1 survey and an in-depth interview
- •Relative Key Informant:
- •Age 18 and older
- •Spouse, blood relative, or caregiver of a cancer patient who identifies as Black/African American
- •Able to read and speak English fluently
- •Able to provide informed consent
- •Able to complete 1 survey and an in-depth interview
- •Provider Key Informant:
- •Age 18 and older
- •Physician, nurse, social worker, patient navigator, or financial counselor
- •Work in oncology setting
- •Able to read and speak English fluently
- •Able to provide informed consent
- •Able to complete 1 survey and an in-depth interview
- •Pilot Tester:
- •Age 18 and older
- •Self-identify as Black/African American
- •Able to read and speak English fluently
- •Able to provide informed consent
- •Newly diagnosed with solid tumor cancer (Stage I-IV)
- •Have not yet consulted with an oncologist regarding treatment
- •Able to complete 2 surveys and an in-depth interview
排除标准
- •Key informants will be excluded from the study if they do not meet the inclusion criteria. Pilot testers will be excluded from the study if they previously participated as key informants and do not meet inclusion criteria.
研究组 & 干预措施
PINPOINT Digital Educational Tool
Newly diagnosed Black cancer patients will be asked to access and engage with the educational website/intervention prototype before their clinic visit or in the clinic immediately before their appointment with their treating oncologist.
干预措施: PINPOINT Digital Educational Tool (Behavioral)
结局指标
主要结局
Community Advisory Board, Key Informants and Pilot Testers
时间窗: June 2021-June 2022
Employ a community-engaged approach, including a Community Advisory Board and key informant interviews, to a) assess knowledge, attitudes, beliefs, and sociocultural, clinical, and system-level factors (e.g., barriers) that may explain disparities in decisions about use of precision oncology in Black cancer patients
Website Development
时间窗: June 2021-June 2023
Utilize this information to guide the iterative development and pilot testing of an innovative, patient-centered and culturally tailored internet-based education and decision support intervention, "Promoting INformed approaches in Precision Oncology and ImmuNoTherapy (PINPOINT)," to reduce racial disparities in access to and use of guideline-based therapy.
次要结局
未报告次要终点
研究者
Anita Y. Kinney, PhD, RN
Study Principal Investigator; Associate Director for Cancer Health Equity
Rutgers, The State University of New Jersey